{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:20:31Z","timestamp":1794579631158,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["K23 MH086690"],"award-info":[{"award-number":["K23 MH086690"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH080880"],"award-info":[{"award-number":["R01 MH080880"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["P50 MH077083"],"award-info":[{"award-number":["P50 MH077083"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1038\/s41386-023-01653-w","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T14:02:27Z","timestamp":1690293747000},"page":"1901-1909","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Functional connectivity of salience and affective networks among remitted depressed patients predicts episode recurrence"],"prefix":"10.1038","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4653-0483","authenticated-orcid":false,"given":"Boadie W.","family":"Dunlop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1189-2051","authenticated-orcid":false,"given":"Jungho","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Sueng","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7867-1160","authenticated-orcid":false,"given":"Charles B.","family":"Nemeroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9957-0027","authenticated-orcid":false,"given":"W. Edward","family":"Craighead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1672-2716","authenticated-orcid":false,"given":"Helen S.","family":"Mayberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"1653_CR1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0006-3223(98)00110-3","volume":"44","author":"MB Keller","year":"1998","unstructured":"Keller MB, Boland RJ. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatry. 1998;44:348\u201360.","journal-title":"Biol Psychiatry"},{"key":"1653_CR2","first-page":"5","volume":"62","author":"J Greden","year":"2001","unstructured":"Greden J. The burden of recurrent depression: causes, consequences, and future prospects. J Clin Psychiatr. 2001;62:5\u20139.","journal-title":"J Clin Psychiatr"},{"key":"1653_CR3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cpr.2015.02.003","volume":"41","author":"CL Bockting","year":"2015","unstructured":"Bockting CL, Hollon SD, Jarrett RB, Kuyken W, Dobson K. A lifetime approach to major depressive disorder: the contributions of psychological interventions in preventing relapse and recurrence. Clin Psychol Rev. 2015;41:16\u201326.","journal-title":"Clin Psychol Rev"},{"key":"1653_CR4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1176\/appi.ajp.2015.15040476","volume":"173","author":"J Guidi","year":"2016","unstructured":"Guidi J, Tomba E, Fava GA. The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature. Am J Psychiatry. 2016;173:128\u201337.","journal-title":"Am J Psychiatry"},{"key":"1653_CR5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1017\/S0033291707000074","volume":"37","author":"C Mattison","year":"2007","unstructured":"Mattison C, Bogren M, Horstmann V, Munk-Jorgensen P, Nettelbrandt P. The long-term course of depressive disorders in the Lundby Study. Psychol Med. 2007;37:883\u201391.","journal-title":"Psychol Med"},{"key":"1653_CR6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archpsyc.65.5.513","volume":"65","author":"WW Eaton","year":"2008","unstructured":"Eaton WW, Shao H, Nestadt G, Lee HB, Bienvenu OJ, Zandi P. Population-based study of first onset and chronicity in major depressive disorder. Arch Gen Psychiatry. 2008;65:513\u201320.","journal-title":"Arch Gen Psychiatry"},{"key":"1653_CR7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S0033291712002395","volume":"43","author":"F Hardeveld","year":"2013","unstructured":"Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman AT. Recurrence of major depressive disorder and its predictors in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med. 2013;43:39\u201348.","journal-title":"Psychol Med"},{"key":"1653_CR8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/JCP.13r08722","volume":"75","author":"S Borges","year":"2014","unstructured":"Borges S, Chen YF, Laughren TP, Temple R, Patel HD, David PA, et al. Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration. J Clin Psychiatry. 2014;75:205\u201314.","journal-title":"J Clin Psychiatry"},{"key":"1653_CR9","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4088\/JCP.v68n0812","volume":"68","author":"M Keller","year":"2007","unstructured":"Keller M, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, et al. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the two-year and combined maintenance phases. J Clin Psychiatry. 2007;68:1246\u201356.","journal-title":"J Clin Psychiatry"},{"key":"1653_CR10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/YIC.0b013e328314e2cb","volume":"23","author":"SG Kornstein","year":"2008","unstructured":"Kornstein SG, Kocsis JH, Ahmed S, Thase M, Friedman ES, Dunlop BW, et al. Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg\/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study. Int Clin Psychopharmacol. 2008;23:357\u201363.","journal-title":"Int Clin Psychopharmacol"},{"key":"1653_CR11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/archpsyc.1992.01820100026006","volume":"49","author":"MT Shea","year":"1992","unstructured":"Shea MT, Elkin I, Imber SD, Sotsky SM, Watkins JT, Collins JF, et al. Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Arch Gen Psychiatry. 1992;49:782\u20137.","journal-title":"Arch Gen Psychiatry"},{"key":"1653_CR12","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/sj.npp.1301131","volume":"31","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 2006;31:1841\u201353.","journal-title":"Neuropsychopharmacology"},{"key":"1653_CR13","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1176\/ajp.156.7.1000","volume":"156","author":"TI Mueller","year":"1999","unstructured":"Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry. 1999;156:1000\u20136.","journal-title":"Am J Psychiatry"},{"key":"1653_CR14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1017\/S003329170300744X","volume":"33","author":"N Kennedy","year":"2003","unstructured":"Kennedy N, Abbott R, Paykel ES. Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychol Med. 2003;33:827\u201338.","journal-title":"Psychol Med"},{"key":"1653_CR15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1017\/S0033291703007827","volume":"33","author":"T Kanai","year":"2003","unstructured":"Kanai T, Takeuchi H, Furukawa TA, Yoshimura R, Imaizumi T, Kitamura T, et al. Time to recurrence after recovery from major depressive episodes and its predictors. Psychol Med. 2003;33:839\u201345.","journal-title":"Psychol Med"},{"key":"1653_CR16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cpr.2018.07.005","volume":"64","author":"JEJ Buckman","year":"2018","unstructured":"Buckman JEJ, Underwood A, Clarke K, Saunders R, Hollon SD, Fearon P, et al. Pilling S. Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis. Clin Psychol Rev. 2018;64:13\u201338.","journal-title":"Clin Psychol Rev"},{"key":"1653_CR17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41380-019-0585-z","volume":"25","author":"M Kennis","year":"2020","unstructured":"Kennis M, Gerritsen L, van Dalen M, Williams A, Cuijpers P, Bockting C. Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis. Mol Psychiatry. 2020;25:321\u201338.","journal-title":"Mol Psychiatry"},{"key":"1653_CR18","volume":"11","author":"RJT Mocking","year":"2021","unstructured":"Mocking RJT, Naviaux JC, Li K, Wang L, Monk JM, Bright AT, et al. Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence. Transl Psychiatry. 2021;11:37.","journal-title":"Transl Psychiatry"},{"key":"1653_CR19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.biopsych.2011.03.009","volume":"70","author":"NA Farb","year":"2011","unstructured":"Farb NA, Anderson AK, Bloch RT, Segal ZV. Mood-linked responses in medial prefrontal cortex predict relapse in patients with recurrent unipolar depression. Biol Psychiatry. 2011;70:366\u201372.","journal-title":"Biol Psychiatry"},{"key":"1653_CR20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jamapsychiatry.2015.1813","volume":"72","author":"KE Lythe","year":"2015","unstructured":"Lythe KE, Moll J, Gethin JA, Workman CI, Green S, Lambon Ralph MA, et al. Self-blame-selective hyperconnectivity between anterior temporal and subgenual cortices and prediction of recurrent depressive episodes. JAMA Psychiatry. 2015;72:1119\u201326.","journal-title":"JAMA Psychiatry"},{"key":"1653_CR21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1017\/S0033291716002567","volume":"47","author":"CI Workman","year":"2017","unstructured":"Workman CI, Lythe KE, McKie S, Moll J, Gethin JA, Deakin JF, et al. A novel resting-state functional magnetic resonance imaging signature of resilience to recurrent depression. Psychol Med. 2017;47:597\u2013607.","journal-title":"Psychol Med"},{"key":"1653_CR22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.nicl.2018.10.004","volume":"20","author":"SA Langenecker","year":"2018","unstructured":"Langenecker SA, Jenkins LM, Stange JP, Chang YS, DelDonno SR, Bessette KL, et al. Cognitive control neuroimaging measures differentiate between those with and without future recurrence of depression. Neuroimage Clin. 2018;20:1001\u20139.","journal-title":"Neuroimage Clin"},{"key":"1653_CR23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","volume":"72","author":"RH Kaiser","year":"2015","unstructured":"Kaiser RH, Andrews-Hanna JR, Wager TD, et al. Large-scale network dysfunction in major depressive disorder: A meta-analysis of resting-state functional connectivity. JAMA Psychiatry. 2015;72:603\u201311.","journal-title":"JAMA Psychiatry"},{"key":"1653_CR24","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-13-106","volume":"13","author":"BW Dunlop","year":"2012","unstructured":"Dunlop BW, Binder EB, Cubells JF, Goodman MG, Kelley ME, Kinkead B, et al. Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials 2012;13:106.","journal-title":"Trials"},{"key":"1653_CR25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1176\/appi.ajp.2016.16050517","volume":"174","author":"BW Dunlop","year":"2017","unstructured":"Dunlop BW, Kelley ME, Aponte-Rivera V, Kelley ME, McGrath CL, Choi KS, et al. Effects of patient preferences on outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study. Am J Psychiatry. 2017;174:546\u201356.","journal-title":"Am J Psychiatry"},{"key":"1653_CR26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1176\/appi.ajp.21070727","volume":"180","author":"BW Dunlop","year":"2023","unstructured":"Dunlop BW, Cha J, Choi KS, Rajendra JK, Nemeroff CB, Craighead WE, et al. Shared and unique changes in brain connectivity among depressed patients remitting with pharmacotherapy versus psychotherapy. Am J Psychiatry. 2023;180:218\u201329.","journal-title":"Am J Psychiatry"},{"key":"1653_CR27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1037\/ccp0000279","volume":"86","author":"JC Kennedy","year":"2018","unstructured":"Kennedy JC, Dunlop BW, Craighead LW, Nemeroff CB, Mayberg HS, Craighead WE. Follow-up of monotherapy remitters in the PReDICT study: Maintenance treatment outcomes and clinical predictors of recurrence. J Consult Clin Psychol. 2018;86:189\u201399.","journal-title":"J Consult Clin Psychol"},{"key":"1653_CR28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/da.22153","volume":"31","author":"V Aponte Rivera","year":"2014","unstructured":"Aponte Rivera V, Dunlop BW, Ramirez C, Kelley ME, Schneider R, Blastos B, et al. Enhancing Hispanic participation in mental health clinical research: Development of a Spanish-speaking depression research site. Depress Anxiety. 2014;31:258\u201367.","journal-title":"Depress Anxiety"},{"key":"1653_CR29","volume-title":"Structured clinical interview for DSM-IV-TR axis I disorders, clinical trials version (SCID-CT)","author":"MB First","year":"2007","unstructured":"First MB, Williams JB, Spitzer RL, Gibbon M. Structured clinical interview for DSM-IV-TR axis I disorders, clinical trials version (SCID-CT). New York: Biometrics Research, New York State Psychiatric Institute; 2007."},{"key":"1653_CR30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1653_CR31","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archpsyc.1987.01800180050009","volume":"44","author":"MB Keller","year":"1987","unstructured":"Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, et al. The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44:540\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"1653_CR32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50\u201355.","journal-title":"Br J Med Psychol"},{"key":"1653_CR33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/mrm.10680","volume":"51","author":"KA Heberlein","year":"2004","unstructured":"Heberlein KA, Hu X. Simultaneous acquisition of gradient-echo and asymmetric spin-echo for single-shot z-shim: Z-SAGA. Magn Reson Med. 2004;51:212\u20136.","journal-title":"Magn Reson Med"},{"key":"1653_CR34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/cbmr.1996.0014","volume":"29","author":"RW Cox","year":"1996","unstructured":"Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 1996;29:162\u201373.","journal-title":"Comput Biomed Res"},{"key":"1653_CR35","doi-asserted-by":"publisher","unstructured":"Jo HJ, Gotts SJ, Reynolds RC, Bandettini PA, Martin A, Cox RW, et al. Effective preprocessing procedures virtually eliminate distance-dependent motion artifacts in resting state FMRI. J Appl Math. 2013; 2013: https:\/\/doi.org\/10.1155\/2013\/935154.","DOI":"10.1155\/2013\/935154"},{"key":"1653_CR36","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F","volume":"42","author":"RW Cox","year":"1999","unstructured":"Cox RW, Jesmanowicz A. Real-time 3D image registration for functional MRI. Magn Reson Med. 1999;42:1014\u20138.","journal-title":"Magn Reson Med"},{"key":"1653_CR37","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.neuroimage.2011.10.018","volume":"59","author":"JD Power","year":"2012","unstructured":"Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage 2012;59:2142\u201354.","journal-title":"Neuroimage"},{"key":"1653_CR38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neuroimage.2010.04.246","volume":"52","author":"HJ Jo","year":"2010","unstructured":"Jo HJ, Saad ZS, Simmons WK, Milbury LA, Cox RW. Mapping sources of correlation in resting state FMRI, with artifact detection and removal. Neuroimage 2010;52:571\u201382.","journal-title":"Neuroimage"},{"key":"1653_CR39","doi-asserted-by":"crossref","first-page":"12569","DOI":"10.1073\/pnas.0800005105","volume":"105","author":"D Sridharan","year":"2008","unstructured":"Sridharan D, Levitin DJ, Menon V. A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks. Proc Natl Acad Sci USA. 2008;105:12569\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1653_CR40","doi-asserted-by":"crossref","first-page":"11020","DOI":"10.1073\/pnas.1000446107","volume":"107","author":"YI Sheline","year":"2010","unstructured":"Sheline YI, Price JL, Yan Z, Mintun MA. Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc Natl Acad Sci USA. 2010;107:11020\u201325.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1653_CR41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/B978-0-12-397025-1.00052-X","volume-title":"Brain Mapping: An Encyclopedic Reference. Vol. 2","author":"V Menon","year":"2015","unstructured":"Menon V. Salience network. In: Toga AW, editor. Brain Mapping: An Encyclopedic Reference. Vol. 2. London: Academic Press, Elsevier; 2015. p. 597\u201311."},{"key":"1653_CR42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/brain.2016.0475","volume":"7","author":"RW Cox","year":"2017","unstructured":"Cox RW, Chen G, Glen DR, Reynolds RC, Taylor PA. FMRI Clustering in AFNI: False-positive rates redux. Brain Connect. 2017;7:152\u201371.","journal-title":"Brain Connect"},{"key":"1653_CR43","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1152\/jn.00338.2011","volume":"106","author":"BT Yeo","year":"2011","unstructured":"Yeo BT, Krienen FM, Sepulcre J, et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol. 2011;106:1125\u201365.","journal-title":"J Neurophysiol"},{"key":"1653_CR44","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamapsychiatry.2013.1969","volume":"70","author":"RB Jarrett","year":"2013","unstructured":"Jarrett RB, Minhajuddin A, Gershenfeld H, Friedman ES, Thase ME. Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: A randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo. JAMA Psychiatry. 2013;70:1152\u201360.","journal-title":"JAMA Psychiatry"},{"key":"1653_CR45","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/da.23108","volume":"38","author":"TS Blank","year":"2021","unstructured":"Blank TS, Meyer BM, Rabl U, Sch\u00f6gl P, Wieser MK, Pezawas L. Neurobiological predictors for clinical trajectories in fully remitted depressed patients. Depress Anxiety. 2021;38:447\u201355.","journal-title":"Depress Anxiety"},{"key":"1653_CR46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2045-5380-4-5","volume":"4","author":"MT Treadway","year":"2014","unstructured":"Treadway MT, Pizzagalli DA. Imaging the pathophysiology of major depressive disorder - from localist models to circuit-based analysis. Biol Mood Anxiety Disord. 2014;4:5.","journal-title":"Biol Mood Anxiety Disord"},{"key":"1653_CR47","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/jamapsychiatry.2015.1376","volume":"72","author":"JP Hamilton","year":"2015","unstructured":"Hamilton JP, Sacchet MD, Gotlib IH. Meta-analysis of functional neuroimaging of major depressive disorder in youth. JAMA Psychiatry. 2015;72:1045\u201353.","journal-title":"JAMA Psychiatry"},{"key":"1653_CR48","doi-asserted-by":"crossref","first-page":"102758","DOI":"10.1016\/j.nicl.2021.102758","volume":"31","author":"G Li","year":"2021","unstructured":"Li G, Liu Y, Zheng Y, Wu Y, Li D, Liang X, et al. Multiscale neural modeling of resting-state fMRI reveals executive-limbic malfunction as a core mechanism in major depressive disorder. Neuroimage Clin. 2021;31:102758.","journal-title":"Neuroimage Clin"},{"key":"1653_CR49","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archpsyc.63.7.749","volume":"63","author":"ZV Segal","year":"2006","unstructured":"Segal ZV, Kennedy S, Gemar M, Hood K, Pedersen R, Buis T. Cognitive reactivity to sad mood provocation and the prediction of depressive relapse. Arch Gen Psychiatry. 2006;63:749\u201355.","journal-title":"Arch Gen Psychiatry"},{"key":"1653_CR50","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jad.2015.06.048","volume":"185","author":"CLH Bockting","year":"2015","unstructured":"Bockting CLH, Smid NH, Koeter MWJ, Spinhoven P, Beck AT, Schene AH. Enduring effects of preventive cognitive therapy in adults remitted from recurrent depression: a 10 year follow-up of a randomized controlled trial. J Affect Disord. 2015;185:188\u201394.","journal-title":"J Affect Disord"},{"key":"1653_CR51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S2215-0366(18)30100-7","volume":"5","author":"CLH Bockting","year":"2018","unstructured":"Bockting CLH, Klein NS, Elgersma HJ, van Rijsbergen GD, Slofstra C, Ormel J, et al. Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised control. Lancet Psychiatry. 2018;5:401\u201310.","journal-title":"Lancet Psychiatry"},{"key":"1653_CR52","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jad.2014.12.016","volume":"174","author":"KEM Biesheuvel-Leliefeld","year":"2015","unstructured":"Biesheuvel-Leliefeld KEM, Kok GD, Bockting CLH, Cuijpers P, Hollon SD, Van Marwijk HWJ, et al. Effectiveness of psychological interventions in preventing recurrence of depressive disorder: meta-analysis and metaregression. J Affect Disord. 2015;174:400\u201310.","journal-title":"J Affect Disord"},{"key":"1653_CR53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamapsychiatry.2019.3351","volume":"77","author":"D Janiri","year":"2020","unstructured":"Janiri D, Moser DA, Doucet GE, Luber MJ, Rasgon A, Lee WH, et al. Shared neural phenotypes for mood and anxiety disorders: A meta-analysis of 226 task-related functional imaging studies. JAMA Psychiatry. 2020;77:172\u20139.","journal-title":"JAMA Psychiatry"},{"key":"1653_CR54","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.neuroimage.2013.05.099","volume":"83","author":"RM Birn","year":"2013","unstructured":"Birn RM, Molloy EK, Patriat R, Parker T, Meier TB, Kirk GR, et al. The effect of scan length on the reliability of resting-state fMRI connectivity estimates. Neuroimage 2013;83:550\u20138.","journal-title":"Neuroimage"},{"key":"1653_CR55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99845-1","volume":"11","author":"C Brydges","year":"2021","unstructured":"Brydges C, Fiehn O, Mayberg HS, Schreiber H, MahmoudianDehkodori S, Bhattacharyya S, et al. Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its fMRI-based neurologic signature. Sci Rep. 2021;11:21011.","journal-title":"Sci Rep"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01653-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01653-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01653-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T14:08:49Z","timestamp":1699884529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01653-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":55,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1653"],"URL":"https:\/\/doi.org\/10.1038\/s41386-023-01653-w","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,25]]},"assertion":[{"value":"3 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Dunlop has received research support from Boehringer Ingelheim, Compass Pathways, NIMH, Otsuka, Sage, Usona Institute, and Takeda and has served as a consultant for Biohaven, Cerebral Therapeutics, Greenwich Biosciences, Myriad Neuroscience, NRx Pharmaceuticals, Otsuka, Sage, and Sophren Therapeutics. Dr. Cha reports no financial relationships with commercial interests. Dr. Choi has served as a consultant for Abbott Laboratories. Dr. Nemeroff has served as a consultant for AbbVie, ANeuroTech (division of Anima BV), Signant Health, Magstim, Inc., Intra-Cellular Therapies, Inc., EMA Wellness, Sage, Silo Pharma, Engrail Therapeutics, Pasithea Therapeutic Corp., GoodCap Pharmaceuticals, Inc., Senseye, Clexio, Ninnion Therapeutics, EmbarkNeuro, SynapseBio, BioXcel Therapeutics, and Relmada Therapeutics; he has served on scientific advisory boards ANeuroTech (division of Anima BV), Brain and Behavior Research Foundation (BBRF), Anxiety and Depression Association of America (ADAA), Skyland Trail, Signant Health, Laureate Institute for Brain Research (LIBR), Inc., Heading Health, Pasithea Therapeutic Corp., and Sage; he holds stock in Seattle Genetics, Antares, Inc., Corcept Therapeutics Pharmaceuticals Company, EMA Wellness, Naki Health, Relmada Therapeutics; he serves on the Board of Directors for Gratitude America, ADAA, and Lucy Scientific Discovery, Inc.; and he is named on U.S. patents 6,375,990B1 and 7,148,027B2. Dr. Craighead serves on the National Advisory Board for the George West Mental Health Foundation, as a board member of Hugarheill ehf (an Icelandic company dedicated to the prevention of depression), and as a scientific advisory board member for AIM for Mental Health and the Anxiety and Depression Association of America; he is supported by the Mary and John Brock Foundation, the Pitts Foundation, and the Fuqua family foundations; and he receives book royalties from John Wiley. Dr. Mayberg has received consulting and intellectual property licensing fees from Abbott Neuromodulation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}